Rice Partnership, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Rice Partnership, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2022$213,000
-13.1%
2,749
-3.8%
0.06%
-12.9%
Q4 2021$245,000
+6.5%
2,8590.0%0.07%
-4.1%
Q3 2021$230,0000.0%2,8590.0%0.07%
+1.4%
Q2 2021$230,000
-4.6%
2,8590.0%0.07%
-16.3%
Q1 2021$241,000
+5.2%
2,8590.0%0.09%0.0%
Q4 2020$229,000
-0.4%
2,8590.0%0.09%
-14.0%
Q3 2020$230,000
-5.3%
2,859
+2.9%
0.10%
-34.2%
Q3 2019$243,000
+6.6%
2,7790.0%0.15%
-1.3%
Q2 2019$228,000
+0.9%
2,7790.0%0.15%
-6.1%
Q1 2019$226,000
+5.6%
2,7790.0%0.16%
+21.5%
Q3 2018$214,000
-40.6%
2,779
-43.0%
0.14%
-43.0%
Q2 2018$360,000
+13.6%
4,8790.0%0.24%
+12.3%
Q1 2018$317,000
+0.6%
4,8790.0%0.21%
-4.5%
Q4 2017$315,0004,8790.22%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders